According to a newly published market research report by 24LifeSciences, the global Argatroban market was valued at USD 54.0 million in 2024 and is projected to reach USD 35.3 million by 2031, declining at a compound annual growth rate (CAGR) of -6.1% during the forecast period 2025–2031. Argatroban, a synthetic direct thrombin inhibitor, is a critical anticoagulant medication...